Amedica (AMDA) Misses Q1 Estimates on Top and Bottom Lines

Amedica (NASDAQ: AMDA) reported Q1 EPS of ($0.30), $0.05 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $4.98 million.

For earnings history and earnings-related data on Amedica (AMDA) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• InspireMD (NSPR) Tops Q2 EPS by 1c
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c